Cite
HARVARD Citation
Bamba, R. et al. (2022). Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice. Journal of cachexia, sarcopenia and muscle. 13 (1), pp. 574-588. [Online].